USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.6.0

Summary

Query: Party Name contains all words: NOVARTIS AG
Number of results: 276+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

86902360
07/26/2017

Glaxo Group Limited
Mark: QYNAETA S#:86902360

Novartis AG

86902351
07/26/2017

Glaxo Group Limited
Mark: QUYNAETA S#:86902351

Novartis AG

87334209
07/14/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: KYPLEETA S#:87334209

Novartis AG

87334207
07/14/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: KIPLYTA S#:87334207

Novartis AG
Novartis AG

86089221
07/14/2017

Azanta A/S
Mark: NIMORAL S#:86089221

Novartis AG

87384621
06/30/2017

Bayer Aktiengesellschaft
Mark: GRANVIO S#:87384621

Novartis AG

87320935
06/20/2017

AbbVie Biotechnology Ltd.
Mark: SKYRIZI S#:87320935

Novartis AG

87276280
06/19/2017

Johnson & Johnson
Mark: RIZEMBRA S#:87276280

Novartis AG

87311918
06/15/2017

Corbus Pharmaceuticals, Inc.
Mark: RESTANVIA S#:87311918

Novartis AG

87232880
06/15/2017

Novartis AG
Mark: TYNFICADE S#:87232880

JANSSEN BIOTECH, INC

87324607
06/13/2017

Dauus Company LLC
Mark: ZORTAX S#:87324607

Novartis AG

91234784
05/30/2017

Leadiant Biosciences Limited
Mark: KYMITA S#:87300964

Novartis AG
Mark: KYNVYTA S#:79186275 R#:5033986

87201770
05/22/2017

Galway Licensing Pty Ltd.
Mark: ACCALIA S#:87201770

Novartis AG

79192250
04/05/2017

FARMACEUTICI DAMOR S.P.A.
Mark: RIGENASE S#:79192250

Novartis AG

87224101
03/30/2017

Impleo Medical, Inc.
Mark: ALUVRA S#:87224101

Novartis AG

87222187
03/09/2017

Novartis AG
Mark: ZIBITRO S#:87222187

JAZZ PHARMACEUTICALS, INC.

87143093
03/07/2017

Celgene Corporation
Mark: ROVIVZEL S#:87143093

Novartis AG

86972596
03/07/2017

Celgene Corporation
Mark: OZMUNE S#:86972596

Novartis AG

87158200
02/21/2017

Glaxo Group Limited
Mark: WISGEMA S#:87158200

Novartis AG

87150030
02/10/2017

Akcea Therapeutics, Inc.
Mark: WAYLIVRA S#:87150030

Novartis AG

86861537
01/16/2017

Recro Pharma, Inc.
Mark: XERIV S#:86861537

Novartis AG
Bristol-Myers Squibb Company

87052637
01/10/2017

Bayer Intellectual Property GmbH
Mark: BREELIB S#:87052637

Novartis AG

86861551
01/04/2017

Recro Pharma, Inc.
Mark: XOLIV S#:86861551

Novartis AG

86879942
12/20/2016

Bayer Intellectual Property GmbH
Mark: BREELIB S#:86879942

Novartis AG

87089125
12/20/2016

Rare Antibody Antigen Supply, Inc.
Mark: KUNASEE S#:87089125

Novartis AG